Drug regulator approves Hyderabad-based Biological E's phase I/II trials of Covid vaccine

Biological E has got the technology transferred from US drug maker Johnson and Johnson (J&J). J&J has also given manufacturing rights of its SARS-Cov2 vaccine to Biological E, a move that could bring J&J’s vaccine to India by mid 2021.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3e1eTxP
via IFTTT